ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS (AZN) - Price, trends, fundamentals and chart - Passport to Wall Street

ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS (NASDAQ: AZN)

Overview

current price

$68.36

$68.36

change

0.00 | 0.00%

0.00 | 0.00%

Yesterday's Close

68.36

open

0.00

volume

0.00 M

30d. avg volume.

5.11 M

1 day

0.00 - 0.00

52 weeks

60.47 - 76.56

p/e

32.40

beta

0.4971

market cap

211.95 B

dividend yield

2.07%

Industry

-

News and Commentary

US Labor Market Heats Up In March: Payrolls Grow By 303,000, Highest In 10 Months, Dampen June Rate... The pace of expansion in the U.S. labor market exceeded forecasts last month, dampening investor hopes for potential interest rate cuts by the Federal Reserve.

Pharma Continues Its Ongoing Battle Against Cancer Last Tuesday, Pfizer Inc (PFE

AstraZeneca To Acquire US Respiratory Vaccine Player Icosavax For Over $800M AstraZeneca Plc (AZN&nb...

Drugmakers Agree To Participate For Medicare Drug Price Negotiation With Biden Administration All ten manufacturers of the first drugs selected for Medicare price negotiations will be participating, the White House said, even though many of them are suing the administrati...

Pharma Giants Shift Stance, Embrace Medicare Negotiations Amid Rising Drug Costs AstraZeneca Plc (AZN&nb...

CDC Backs Pfizer's RSV Infection Maternal Vaccine During Pregnancy As Protection For Infants Friday, The Centers for Disease Control and Prevention recommended the first respiratory syncytial virus (RSV) vaccine for pregnant people to protect their newborns from severe R...

Biden Administration Vs. Big Pharma: What the Legal Showdown Means for Your Wallet The Biden administration's move to lower drug prices has prompted a flurry of legal challenges. While legal experts acknowledge the lack of a clear legal precedent, signs suggest...

Novo Nordisk's Diabetes, Weight Loss Drugs Under UK Scrutiny: Follows Suicidal Behavior Reports The Medicines and Healthcare Products Regulatory Agency (MHRA), the U.K.'s drug regulatory authority, is reportedly scrutinizing a category of drugs used in diabetes medication a...

More than Half of Europe Will be Infected with Omicron, Says WHO More than half of Europe's population could be infected with the highly mutated Omicron variant of COVID-19 over the next six to eight weeks, the World Health Organization (WHO)...

Market Update: Stocks End 2021 in the Gain, Benchmarks Post Double-Digit Gains Stocks finished Friday's session in the red, as market benchmarks closed the last day of 2021 slightly lower, but still within record levels as Wall Street ends a year of growth...

StockTwits

Join now and unlock premium features

Access to premium stock and ETF data including financials, holdings and more
Participate in trading contests and earn real prizes
Sync you favorite articles and symbols between all of your device
And much more